A comprehensive view of Cancer. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.
ANGLE partners with AstraZeneca to enhance cancer drug development using DNA damage response assay; companies to adapt ANGLE's existing Parsortix-based assay for identifying micronuclei in circulating tumor cells
Published:
April 24, 2024
by Proactive Investors
|
US Patent Issued to Bristol-Myers Squibb on April 23 for "[1,2,4triazolo[1,5-apyridinyl substituted indole compounds" (Indian, American Inventors)
Published:
April 24, 2024
by U.S. Fed News
|
US Patent Issued to Regeneron Pharmaceuticals on April 23 for "Methods and compositions for sensitization of tumor cells to immune therapy" (New York, New Jersey Inventors)
Published:
April 24, 2024
by U.S. Fed News
|
FDA accepts for priority review GSK’s application for an expanded indication of Jemperli dostarlimab-gxly plus chemotherapy to include all adult patients with primary advanced or recurrent endometrial cancer
Published:
April 24, 2024
by GSK Group (GlaxoSmithKline)
|
US Patent Issued to ELI LILLY and Co. on April 23 for "Compounds useful for inhibiting RET kinase" (Colorado, Montana Inventors)
Published:
April 24, 2024
by U.S. Fed News
|
Ask us about our Tissue & Hygiene market view